Molecular Signaling Pathways and Therapeutic Targets in Hepatocellular Carcinoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular Signaling Pathways and Therapeutic Targets in Hepatocellular Carcinoma
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 2, Pages 491
Publisher
MDPI AG
Online
2020-02-24
DOI
10.3390/cancers12020491
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Promising diagnostic and prognostic value of E2Fs in human hepatocellular carcinoma
- (2019) Yan-Lin Huang et al. Cancer Management and Research
- Nqo1 ablation inhibits activation of the PI3K/Akt and MAPK/ERK pathways and blocks metabolic adaptation in hepatocellular carcinoma
- (2019) Manali Dimri et al. HEPATOLOGY
- Role of Hippo Pathway-YAP/TAZ Signaling in Angiogenesis
- (2019) Gandhi T. K. Boopathy et al. Frontiers in Cell and Developmental Biology
- The tumor secretory factor ZAG promotes white adipose tissue browning and energy wasting
- (2018) Sawsan Elattar et al. FASEB JOURNAL
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A Novel YAP1 Inhibitor Targets CSC-Enriched Radiation-Resistant Cells and Exerts Strong Antitumor Activity in Esophageal Adenocarcinoma
- (2017) Shumei Song et al. MOLECULAR CANCER THERAPEUTICS
- From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world
- (2017) Dimitrios Dimitroulis et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Implication of the Hedgehog pathway in hepatocellular carcinoma
- (2017) Carminia Maria Della Corte et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Targeting the Ras/Raf/MEK/ERK pathway in hepatocellular carcinoma
- (2017) Sufang Yang et al. Oncology Letters
- A phase I study of AVE1642, a human monoclonal antibody–blocking insulin-like growth factor-1 receptor (IGF-1R), given as a single agent and in combination with sorafenib as first-line therapy in patients with advanced hepatocellular carcinoma (HCC).
- (2017) S. J. Faivre et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II study of cixutumumab (IMC-A12, NSC742460; C) in hepatocellular carcinoma (HCC).
- (2017) G. K. Abou-Alfa et al. JOURNAL OF CLINICAL ONCOLOGY
- Inhibitory effect of bufalin combined with Hedgehog signaling pathway inhibitors on proliferation and invasion and metastasis of liver cancer cells
- (2016) Xia Sheng et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Drug delivery system targeting advanced hepatocellular carcinoma: Current and future
- (2016) Xue Zhang et al. Nanomedicine-Nanotechnology Biology and Medicine
- Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma
- (2016) Edward K. Geissler et al. TRANSPLANTATION
- Sonic hedgehog pathway inhibitor mitigates mouse hepatocellular carcinoma
- (2015) Kuo-Shyang Jeng et al. AMERICAN JOURNAL OF SURGERY
- Molecular Targeted Therapy for Hepatocellular Carcinoma: Present Status and Future Directions
- (2015) Kyung-Ju Choi et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours
- (2015) S J Thomas et al. BRITISH JOURNAL OF CANCER
- Ligand and Structure Based Models for the Identification of Beta 2 Adrenergic Receptor Antagonists
- (2015) Jayadev Joshi et al. Current Computer-Aided Drug Design
- Signal transducer and activator of transcription 3-mediated CD133 up-regulation contributes to promotion of hepatocellular carcinoma
- (2015) Cheolhee Won et al. HEPATOLOGY
- New molecularly targeted therapies against advanced hepatocellular carcinoma: From molecular pathogenesis to clinical trials and future directions
- (2015) Makoto Chuma et al. HEPATOLOGY RESEARCH
- Phase I/II safety and antitumor activity of nivolumab in patients with advanced hepatocellular carcinoma (HCC): CA209-040.
- (2015) Anthony B. El-Khoueiry et al. JOURNAL OF CLINICAL ONCOLOGY
- Todralazine Protects Zebrafish from Lethal Effects of Ionizing Radiation: Role of Hematopoietic Cell Expansion
- (2015) Manali Dimri et al. Zebrafish
- Antitumor Effects in Hepatocarcinoma of Isoform-Selective Inhibition of HDAC2
- (2014) Yun-Han Lee et al. CANCER RESEARCH
- Molecular Therapies in Hepatocellular Carcinoma: What Can We Target?
- (2014) Roberto Galuppo et al. DIGESTIVE DISEASES AND SCIENCES
- The clinically used photosensitizer Verteporfin (VP) inhibits YAP-TEAD and human retinoblastoma cell growth in vitro without light activation
- (2014) Katarzyna Brodowska et al. EXPERIMENTAL EYE RESEARCH
- Review of angiogenesis in hepatocellular carcinoma
- (2014) Jun Muto et al. HEPATOLOGY RESEARCH
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib
- (2014) Andrew X. Zhu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Development of a Novel Azaspirane That Targets the Janus Kinase-Signal Transducer and Activator of Transcription (STAT) Pathway in Hepatocellular Carcinomain Vitroandin Vivo
- (2014) Chakrabhavi Dhananjaya Mohan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Roles of Tregs in development of hepatocellular carcinoma: A meta-analysis
- (2014) Hong-Qiang Zhao WORLD JOURNAL OF GASTROENTEROLOGY
- The genetic and epigenetic alterations in human hepatocellular carcinoma: a recent update
- (2014) Ming Liu et al. Protein & Cell
- Effect of Mst1 overexpression on the growth of human hepatocellular carcinoma HepG2 cells and the sensitivity to cisplatin in vitro
- (2013) C. Xu et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Therapeutic Targeting of the JAK/STAT Pathway
- (2013) Saara Aittomäki et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma
- (2013) Z. Kan et al. GENOME RESEARCH
- Hedgehog signaling pathway regulates autophagy in human hepatocellular carcinoma cells
- (2013) Ying Wang et al. HEPATOLOGY
- Epidemiology of Hepatocellular Carcinoma
- (2013) Sahil Mittal et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
- (2013) Philip J. Johnson et al. JOURNAL OF CLINICAL ONCOLOGY
- Brivanib in Patients With Advanced Hepatocellular Carcinoma Who Were Intolerant to Sorafenib or for Whom Sorafenib Failed: Results From the Randomized Phase III BRISK-PS Study
- (2013) Josep M. Llovet et al. JOURNAL OF CLINICAL ONCOLOGY
- Sunitinib Versus Sorafenib in Advanced Hepatocellular Cancer: Results of a Randomized Phase III Trial
- (2013) Ann-Lii Cheng et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinoma
- (2012) Han Chong Toh et al. CANCER
- Hedgehog Signaling Blockade Delays Hepatocarcinogenesis Induced by Hepatitis B Virus X Protein
- (2012) A. Arzumanyan et al. CANCER RESEARCH
- Novel therapeutic Strategies for Targeting Liver Cancer Stem Cells
- (2012) Naoki Oishi et al. International Journal of Biological Sciences
- Hepatocellular carcinoma – Authors' reply
- (2012) Alejandro Forner et al. LANCET
- Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study
- (2012) Armando Santoro et al. LANCET ONCOLOGY
- Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells
- (2012) Nicole Grabinski et al. Molecular Cancer
- Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma
- (2011) Qian Zhou et al. Future Oncology
- The changing pattern of epidemiology in hepatocellular carcinoma
- (2010) Helena Nordenstedt et al. DIGESTIVE AND LIVER DISEASE
- PD-1 and PD-L1 upregulation promotes CD8+ T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients
- (2010) Feng Shi et al. INTERNATIONAL JOURNAL OF CANCER
- Hepatocellular carcinoma: a global view
- (2010) Ju Dong Yang et al. Nature Reviews Gastroenterology & Hepatology
- The role of signaling pathways in the development and treatment of hepatocellular carcinoma
- (2010) S Whittaker et al. ONCOGENE
- Early and very early hepatocellular carcinoma: when and how much do staging and choice of treatment really matter? A multi-center study
- (2009) Fabio Farinati et al. BMC CANCER
- Kupffer Cell Suppression of CD8+ T Cells in Human Hepatocellular Carcinoma Is Mediated by B7-H1/Programmed Death-1 Interactions
- (2009) K. Wu et al. CANCER RESEARCH
- Hepatocellular carcinoma and the ubiquitin–proteasome system
- (2008) Simon P. Dawson BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Live or Let Die: E2F1 and PI3K Pathways Intersect to Make Life or Death Decisions
- (2008) Brian David Dynlacht CANCER CELL
- E2F1 Inhibits c-Myc-Driven Apoptosis via PIK3CA/Akt/mTOR and COX-2 in a Mouse Model of Human Liver Cancer
- (2008) Sara Ladu et al. GASTROENTEROLOGY
- Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma
- (2008) Augusto Villanueva et al. GASTROENTEROLOGY
- Expression of Yes-associated protein in common solid tumors
- (2008) Angela A. Steinhardt et al. HUMAN PATHOLOGY
- Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma
- (2008) W. Song et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation
- (2008) Lijian Hui et al. JOURNAL OF CLINICAL INVESTIGATION
- Phase II Trial Evaluating the Clinical and Biologic Effects of Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2008) Abby B. Siegel et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Development of Hepatocellular Carcinoma in Iqgap2-Deficient Mice Is IQGAP1 Dependent
- (2008) V. A. Schmidt et al. MOLECULAR AND CELLULAR BIOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now